Overdiagnosis of Chronic Kidney Disease in Older Adults - An Inconvenient Truth

Ann M. O'Hare; Rudolph A. Rodriguez; Andrew D. Rule

doi:10.1001/jamainternmed.2021.4823

Overdiagnosis of Chronic Kidney Disease in Older Adults - An Inconvenient Truth

Ann M. O'Hare, Rudolph A. Rodriguez, Andrew D. Rule

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1366-1368
Number of pages	3
Journal	JAMA internal medicine
Volume	181
Issue number	10
DOIs	https://doi.org/10.1001/jamainternmed.2021.4823
State	Published - Oct 2021

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/jamainternmed.2021.4823

Cite this

@article{6ff5a36dc944476384ec4815924c901b,

title = "Overdiagnosis of Chronic Kidney Disease in Older Adults - An Inconvenient Truth",

author = "O'Hare, {Ann M.} and Rodriguez, {Rudolph A.} and Rule, {Andrew D.}",

note = "Funding Information: reported grants from the National Institute of Diabetes and Digestive and Kidney Diseases and VA Health Services Research and Development Service as well as personal fees from Kaiser Southern California, the University of California, San Francisco, American Society of Nephrology, Devenir Foundation, Chugai Pharmaceutical, Japanese Society of Dialysis Therapy, Hammersmith Hospital, UpToDate, and New York Society of Nephrology outside the submitted work. No other disclosures were reported. Funding Information: The 2002 guideline2 was sponsored by the NKF, a nonprofit professional organization that receives funding from pharmaceutical and biotechnology companies whose products are marketed to people with CKD. The 2012 guideline update was sponsored by the Kidney Disease Global Outcomes Initiative (KDIGO), a nonprofit organization that develops and implements evidence-based clinical practice guidelines in kidney disease. KDIGO was originally established by NKF and shares some of the same corporate sponsors. A novel feature of the 2012 guideline update was its reliance on the work of the CKD Prognosis Consortium, which was established by KDIGO in 2009 to support guideline development by conducting research that would fill gaps in the literature and overcome the perceived deficiencies of published studies. The consortium brought together scientific investigators with relevant expertise worldwide to contribute data to patient-level meta-analyses. It was sponsored by the NKF and included members of the KDIGO board and 2012 guideline work group.",

year = "2021",

month = oct,

doi = "10.1001/jamainternmed.2021.4823",

language = "English (US)",

volume = "181",

pages = "1366--1368",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - Overdiagnosis of Chronic Kidney Disease in Older Adults - An Inconvenient Truth

AU - O'Hare, Ann M.

AU - Rodriguez, Rudolph A.

AU - Rule, Andrew D.

N1 - Funding Information: reported grants from the National Institute of Diabetes and Digestive and Kidney Diseases and VA Health Services Research and Development Service as well as personal fees from Kaiser Southern California, the University of California, San Francisco, American Society of Nephrology, Devenir Foundation, Chugai Pharmaceutical, Japanese Society of Dialysis Therapy, Hammersmith Hospital, UpToDate, and New York Society of Nephrology outside the submitted work. No other disclosures were reported. Funding Information: The 2002 guideline2 was sponsored by the NKF, a nonprofit professional organization that receives funding from pharmaceutical and biotechnology companies whose products are marketed to people with CKD. The 2012 guideline update was sponsored by the Kidney Disease Global Outcomes Initiative (KDIGO), a nonprofit organization that develops and implements evidence-based clinical practice guidelines in kidney disease. KDIGO was originally established by NKF and shares some of the same corporate sponsors. A novel feature of the 2012 guideline update was its reliance on the work of the CKD Prognosis Consortium, which was established by KDIGO in 2009 to support guideline development by conducting research that would fill gaps in the literature and overcome the perceived deficiencies of published studies. The consortium brought together scientific investigators with relevant expertise worldwide to contribute data to patient-level meta-analyses. It was sponsored by the NKF and included members of the KDIGO board and 2012 guideline work group.

PY - 2021/10

Y1 - 2021/10

UR - http://www.scopus.com/inward/record.url?scp=85114095839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114095839&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2021.4823

DO - 10.1001/jamainternmed.2021.4823

M3 - Comment/debate

C2 - 34459870

AN - SCOPUS:85114095839

SN - 2168-6106

VL - 181

SP - 1366

EP - 1368

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 10

ER -

Overdiagnosis of Chronic Kidney Disease in Older Adults - An Inconvenient Truth

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this